Changes in ACE2 activity after SARS-CoV-2 infection may be particularly problematic in individuals in whom ACE2 expression is already altered secondary to obesity, diabetes and hypertension [25,26]. The gene discussed is ACE2; the disease is obesity due to melanocortin 4 receptor deficiency.